Conatus Pharmaceuticals was founded by the executive management team of Idun Pharmaceuticals in July 2005 following the successful sale of Idun to Pfizer. At Idun, the Conatus team pioneered the science of apoptosis and the clinical development of pan caspase inhibitors, validating this first-in-class technology. Conatus has well established relationships with key opinion leaders in the fields of hepatology, infectious disease and inflammation. The Conatus team has over 80 years of experience in the pharmaceutical industry and has created multiple successful partnerships with global pharmaceutical companies. The Conatus team has an excellent track record with blue chip investors that are active in financing successful biotechnology companies.

We are building our portfolio in the areas of inflammation and liver disease, including infectious and metabolic diseases. Conatus is a privately held company based in San Diego, California.